DOC's reported 11% revenue growth and record EBIT in Q1. We raise our DCF-based price target to €266 and maintain a BUY rating.

15 Aug 2025
Q1 defies travel fears, growth continues across all segments

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Q1 defies travel fears, growth continues across all segments
- Published:
15 Aug 2025 -
Author:
Henry Wendisch -
Pages:
11 -
DOC's reported 11% revenue growth and record EBIT in Q1. We raise our DCF-based price target to €266 and maintain a BUY rating.